| Photo link |
http://www.swsbm.com/Images/New2-2001/Ginkgo_biloba.jpg |
| Studies on Diabetes |
EGb761 was estimated to be protective against hydroxic damages an rat myocardial microvessals also in diabetic condition (Welt 2001) |
| Other Uses |
Age related macular degeneration, memory impairment, cognitive performance, dementia, intermittent claudication, premenstrual syndrome, Raynauds disease, and vertigo (NMCD; http://www.naturaldatabase.com/monograph.asp?mono_id=333&brand_id=, accessed 4/23/04). |
| Formulations used by Informants |
Commercially prepared tablets/capsules or pills (Diabetifen). |
| Phytochemistry |
Flavonoids, terpenoids (gingkolides A,B,C, M, and J, and bilobalides), and organic acids (NMCD accessed 4/23/04). |
| Potential Adverse Effects |
Mild gastrointestinal distress, headache, dizziness, palpatations, constipation and allergic skin reactions. Large doses can cause restlessness, diarrhea, nausea, vomiting, decreased muscle tone, and weakness. Gingko may also cause bleeding, decrease seiz |
| Potential Medication Interactions |
Gingko can interact with diabetic medications (including insulin), seizure medications, anti-coagulant and antiplatlet medications, Cytochrome P 450 (CYP1A2, CYP2D6, CYP3A4) metabolized medications, trazadone, and thiazide diuretics (NMCD accessed 4/23/04 |
| References |
http://www.itis.usda.gov/index.html |
